If an agonist can produce submaximal effects and has moderate efficacy it’s called:

Questions 52

ATI RN

ATI RN Test Bank

Pharmacology Cardiovascular Drugs Quiz Questions

Question 1 of 5

If an agonist can produce submaximal effects and has moderate efficacy it’s called:

Correct Answer: A

Rationale: The correct answer is A) Partial agonist. In pharmacology, an agonist is a drug that binds to a receptor and activates it to produce a biological response. A partial agonist has moderate efficacy, meaning it can only produce submaximal effects even when all available receptors are occupied. This is in contrast to a full agonist (option D) which can produce maximal effects at full receptor occupancy. Now, let's discuss why the other options are incorrect: - B) Antagonist: An antagonist blocks the action of an agonist by binding to the receptor without activating it. It does not produce any effects on its own, unlike a partial agonist. - C) Agonist-antagonist: This term refers to a drug that has both agonistic and antagonistic properties, acting as an agonist at one type of receptor and as an antagonist at another. It is not the correct term for a drug with moderate efficacy. - D) Full agonist: As mentioned earlier, a full agonist can produce maximal effects at full receptor occupancy, which is different from a partial agonist. Understanding the concept of partial agonists is important in pharmacology as it influences how drugs interact with receptors and modulate biological responses. Knowing the differences between agonists, partial agonists, antagonists, and agonist-antagonists is crucial for prescribing medications and predicting their effects on the body.

Question 2 of 5

Сholinesterase inhibitors do not produce:

Correct Answer: D

Rationale: In pharmacology, cholinesterase inhibitors like neostigmine and pyridostigmine are commonly used to treat conditions like myasthenia gravis by increasing acetylcholine levels at the neuromuscular junction. The correct answer, option D, "Dramatic hypertension and tachycardia," is not produced by cholinesterase inhibitors. Cholinesterase inhibitors typically lead to increased acetylcholine levels, which can cause bradycardia or no change in heart rate due to increased parasympathetic activity. They can also modestly lower blood pressure due to vasodilation. Option A is incorrect because cholinesterase inhibitors can indeed lead to bradycardia and a modest fall in blood pressure. Option B is correct as cholinesterase inhibitors can increase muscle contraction strength, especially in muscles weakened by myasthenia gravis, by enhancing neuromuscular transmission. Educationally, understanding the effects of cholinesterase inhibitors on the cardiovascular system is crucial for safe medication administration and patient care. By grasping these concepts, healthcare professionals can make informed decisions when managing patients on these medications, ensuring optimal therapeutic outcomes while minimizing potential adverse effects.

Question 3 of 5

Skeletal muscle relaxation and paralysis can occur from interruption of functions at several sites, including all of the following EXCEPT:

Correct Answer: B

Rationale: In pharmacology, understanding the mechanisms of skeletal muscle relaxation and paralysis is crucial. In this context, the correct answer, option B) Muscarinic acetylcholine receptors, is not directly involved in skeletal muscle relaxation and paralysis. Muscarinic receptors are mainly found in the autonomic nervous system and are not directly related to skeletal muscle function. Option A) Nicotinic acetylcholine receptors are crucial for neuromuscular transmission at the motor end plate. Interruption of these receptors can lead to skeletal muscle paralysis. Option C) The motor end plate is where the neuromuscular junction is formed, and it is essential for transmitting signals from motor neurons to skeletal muscle fibers. Disruption at this site can indeed cause skeletal muscle relaxation and paralysis. Option D) The contractile apparatus is directly involved in muscle contraction. Interruption at this site would likely lead to muscle dysfunction rather than relaxation or paralysis. Educationally, this question highlights the importance of understanding the specific receptors and sites involved in skeletal muscle function and how disruptions at different points can lead to varying effects on muscle activity. By grasping these concepts, pharmacology students can better comprehend the mechanisms of action of drugs affecting skeletal muscle function.

Question 4 of 5

Which of the following agents is a nonselective beta receptor agonist?

Correct Answer: C

Rationale: In pharmacology, understanding the mechanism of action of drugs is crucial for safe and effective prescribing. In the context of beta receptor agonists, it is important to differentiate between selective and nonselective agents. In this question, the correct answer is C) Isoproterenol. Isoproterenol is a nonselective beta receptor agonist, meaning it stimulates both beta-1 and beta-2 adrenergic receptors. This stimulation leads to increased heart rate, contractility, and bronchodilation. A) Norepinephrine is not a beta receptor agonist but rather an endogenous catecholamine that acts on alpha and beta receptors, leading to vasoconstriction. B) Terbutaline is a selective beta-2 receptor agonist commonly used as a bronchodilator in conditions like asthma and COPD. D) Dobutamine is a selective beta-1 receptor agonist used for its positive inotropic effects in conditions such as heart failure. Understanding the selectivity of beta receptor agonists is crucial in clinical practice to select the most appropriate drug based on the desired effects and potential side effects. This knowledge is essential for healthcare professionals to make informed decisions when managing cardiovascular conditions.

Question 5 of 5

Indicate an alfa-receptor antagonist which binds covalently to alfa receptors causing irreversible blockade of long duration (14-48 hours or longer):

Correct Answer: B

Rationale: In pharmacology, understanding the mechanism of action of drugs is crucial to make informed clinical decisions. In this context, the correct answer is B) Phenoxybenzamine. Phenoxybenzamine is an irreversible alpha-adrenergic receptor antagonist that forms a covalent bond with alpha receptors, leading to long-lasting blockade lasting 14-48 hours or even longer. This irreversible binding distinguishes phenoxybenzamine from other alpha-blockers. Option A) Phentolamine is a reversible competitive alpha-adrenergic receptor antagonist that does not bind covalently to alpha receptors, resulting in a shorter duration of action compared to phenoxybenzamine. Option C) Ergotamine is not an alpha-receptor antagonist but rather a medication used for treating migraines by binding to serotonin receptors. Option D) Prazosin is a reversible alpha-1 adrenergic receptor antagonist that does not form a covalent bond with the receptors, leading to a shorter duration of action compared to phenoxybenzamine. Educationally, understanding the differences in the mechanisms of action of alpha-receptor antagonists is essential for pharmacology students and healthcare professionals to select the most appropriate drug for a given clinical situation. Knowing the specific characteristics of each drug allows for tailored therapy based on the desired duration of action and potential side effects. This knowledge is crucial for optimizing patient care and outcomes in cardiovascular disorders where alpha-receptor antagonists are commonly used.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions